IPAMORELIN

Package contents:

1 box 1 vial

Ipamorelin is a selective GH-secretagogue and Ghrelin receptor agonist. The strength of Ghrelin stimulation is comparable to GHRP6, but it stimulates appetite less.

Unlike other GH secretagogues, this pentapeptide does not release equal amounts of cortisol, acetylcholine, prolactin, and aldosterone.

Therefore, Ipamorelin is considered the first and best selective GH secretagogue.

Ipamorelin is a synthetic peptide that stimulates the release of growth hormone. It belongs to the GHRP (growth hormone releasing peptide) family and acts on Ghrelin receptors to increase the secretion of growth hormone.

Ipamorelin effectively increases the release of growth hormone, which can have many benefits, such as increased muscle mass, reduced body fat, and muscle regeneration. In addition, Ipamorelin does not cause significant side effects such as the release of cortisol or prolactin.

Usage:

Inject at least 200 µg subcutaneously once a day, 5 days a week.

We recommend combining Ipamorelin with CJC-1295 DAC (a tetrasubstituted peptide hormone containing 30 amino acids) as it provides a synergistic effect and provides five times the benefits of using CJC 1295 or Ipamorelin alone. The combination allows for maximum GH release as CJC 1295 and Ipamorelin have different mechanisms of action and act on different receptors (GHRH-R and Ghrelin-R).